51

Skip navigation

Dr Paul Jowsey

Assistant Professor

School: Geography and Natural Sciences

Paul obtained a BSc in Biochemistry from Newcastle University in 1999 before completing a PhD at the Cancer Research Unit at the same Institution. His PhD studies focused on the characterisation of novel post-translational modifications of the p53 tumour suppressor protein. Such studies have been a common theme in Paul’s postdoctoral research, including 3.5 years at the MRC Protein Phosphorylation Unit (University of Dundee), before returning to Newcastle University in 2006.

Since 2006, research interests have included studies to define the genotoxic mechanism of sulphur mustard (a chemical warfare agent), studies to investigate potential adverse effects associated with medical radiation (e.g. X-rays that can cause DNA damage), as well as the identification and characterisation of post-translational modifications in DNA damage response proteins. Paul has published regularly in peer-reviewed journals and obtained independent grant income to pursue his research interests. Alongside his research, Paul also lectured in the areas of ‘Cell Death’, ‘Genotoxicology’ and ‘Genotoxicology & Carcinogenesis’.

Paul joined Northumbria in May 2020 as a Senior Lecturer in Cellular and Molecular Sciences.

Paul Jowsey

Our cells are constantly exposed to endogenous and exogenous agents that can damage our genetic material (DNA) and cause mutations (potentially leading to cancer). In addition, the normal cellular processes of DNA replication and mitosis pose a risk to genomic stability during each cell division, for example due to DNA polymerase errors and/or incorrect segregation of sister chromatids. To protect our DNA, cells have evolved complex protein signalling pathways that control DNA repair and cell cycle regulation. Our research aims to:

1) Characterise novel regulatory mechanisms that help to maintain genomic stability. Current studies involve functional characterisation of novel post translational modifications that we have identified in the microcephalin-1 (MCPH1) tumour suppressor protein

2) Investigate cellular/cytogenetic changes induced by DNA damage that could contribute to disease. Current studies focus on amplification of the c-MYC oncogene after exposure of cells to ionising radiation (X-rays).

3) Identify novel genetic factors and gene-environment interactions that might increase susceptibility to DNA damage and cancer. Current studies focus on the impact of certain environmental factors on cells carrying a mutation in the BRCA1 or BRCA2 breast cancer susceptibility genes.

Such knowledge is essential to understand normal cellular function, understand disease mechanisms and identify potential novel targets for therapeutic intervention.

  • Isobel Chapman Targeting the Microcephalin-1 Tumour Suppressor Protein in Cancer Start Date: 01/10/2022
  • Xueqin Wu Post-translation modification/regulation of the MCPH1 tumour suppressor gene. Start Date: 01/10/2023 End Date: 17/10/2025
  • Isobel Chapman Targeting the Microcephalin-1 Tumour Suppressor Protein in Cancer Start Date: 01/10/2022 End Date: 17/10/2025
  • Xueqin Wu Post-translation modification/regulation of the MCPH1 tumour suppressor gene. Start Date: 01/10/2023

Biochemistry PhD December 03 2003


Latest News and Features

Professor Malcolm von Schantz
Views of Antarctica. Photo by Professor Andrew Shepherd, CPOM.
Student Law Office
Business Clinic with EY
Exterior of the U.S. National Science Foundation (NSF) Daniel K. Inouye Solar Telescope in Hawaii. Credit: NSF/NSO/AURA
51 Business Campus
More news
More events

Upcoming events

Not Your Usual Design
CHASE LECTURE - D6: Culture in Transit
Collaborating for Capability: Shaping the Future of Supply Chain Talent

Back to top